reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - iné prípravky protianemický - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
serlift 50 mg
adamed czech republic s.r.o., Česká republika - sertralín - 30 - antidepressiva
serlift 100 mg
adamed czech republic s.r.o., Česká republika - sertralín - 30 - antidepressiva
bcg-medac
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - bcg vakcína - 59 - immunopraeparata
sertralin actavis 50 mg
teva b.v., holandsko - sertralín - 30 - antidepressiva
sertralin actavis 100 mg
teva b.v., holandsko - sertralín - 30 - antidepressiva
sertraline zentiva
zentiva k.s., Česká republika - sertralín - 30 - antidepressiva
lymphomyosot
biologische heilmittel heel gmbh, nemecko - iné liečivá - 93 - homeopatica
traumeel s tablety
biologische heilmittel heel gmbh, nemecko - iné liečivá - 93 - homeopatica
traumeel s
biologische heilmittel heel gmbh, nemecko - iné liečivá - 93 - homeopatica